Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Daniel Neukomm CSLM CSLM Acquisition Corp. Class A Ordinary Share 13G 19.33% 2y
Kynam Capital Management, LP BNR Burning Rock Biotech Ltd 13G/A 10.19% 2y
HMI Capital Management, L.P. GTLB Gitlab Inc. 13G/A 4.1% 2y
AWM Investment Company, Inc. AMSC American Superconductor Corp 13G/A 7.3% 2y
Alyeska Investment Group, L.P. SRZN Surrozen, Inc. 13G 9.99% 2y
T. Rowe Price Investment Management, Inc. SAM Boston Beer Co Inc 13G/A 9.2% 2y
T. Rowe Price Investment Management, Inc. MGY Magnolia Oil & Gas Corp 13G 5.2% 2y
PERCEPTIVE ADVISORS LLC OBIO Orchestra BioMed Holdings, Inc. 13G/A 6.8% 2y
T. Rowe Price Investment Management, Inc. RGCO Rgc Resources Inc 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. PAYO Payoneer Global Inc. 13G/A 0% 2y
Halis Family Foundation SFES Safeguard Scientifics Inc 13G/A 5.1% 2y
Select Equity Group, L.P. ENTG Entegris Inc 13G/A 4.4% 2y
V. Gordon Clemons CRVL Corvel Corp 13G/A 7.15% 2y
Pfizer Inc ELVN Enliven Therapeutics, Inc. 13G/A 0.95% 2y
PRICE T ROWE ASSOCIATES INC /MD/ IDYA IDEAYA Biosciences, Inc. 13G 5.5% 2y
AMERIPRISE FINANCIAL INC MASS 908 Devices Inc. 13G 5.84% 2y
ARMISTICE CAPITAL, LLC AVGR Avinger, Inc. Common Stock 13G/A 4.99% 2y
GLAZER CAPITAL, LLC CSTAF Constellation Acquisition Corp I 13G/A 0% 2y
Ayrton Capital LLC PMCB PharmaCyte Biotech, Inc. 13G 9.9% 2y
T. Rowe Price Investment Management, Inc. JMSB John Marshall Bancorp, Inc. 13G/A 11% 2y
Jeremy M. Levin OVID Ovid Therapeutics Inc. 13G/A 9.4% 2y
Robert Martin Friedland IE Ivanhoe Electric Inc. 13G 9% 2y
Founders Fund V Management, LLC AMTI Applied Molecular Transport Inc. Common Stock 13G/A 0% 2y
Avoro Capital Advisors LLC UTHR UNITED THERAPEUTICS Corp 13G/A 6.1% 2y
Ayrton Capital LLC PTPI Petros Pharmaceuticals, Inc. 13G 9.9% 2y
Shay Capital LLC TLYS Tilly's, Inc. 13G/A 8.5% 2y
Nantahala Capital Management, LLC SSKN STRATA Skin Sciences, Inc. 13G/A 8.9% 2y
H/2 CREDIT MANAGER LP VRE Veris Residential, Inc. 13G/A 4.66% 2y
Sculptor Capital LP ZEO Zeo Energy Corp. 13G/A 0% 2y
Dengrao Jia GMM Global Mofy AI Ltd 13G 7.95% 2y
AQR CAPITAL MANAGEMENT LLC ACAC Acri Capital Acquisition Corporation Class A Common Stock 13G 5.48% 2y
Aristotle Capital Management, LLC XYL Xylem Inc. 13G/A 3.71% 2y
ARMISTICE CAPITAL, LLC MDGL Madrigal Pharmaceuticals, Inc. 13G/A 0.25% 2y
HG Vora Capital Management, LLC GBTG Global Business Travel Group, Inc. 13G/A 1.7% 2y
ALLIANCEBERNSTEIN L.P. BVFL BV Financial, Inc. 13G 9.2% 2y
Springhouse Capital Management, LP WILCF G Willi Food International Ltd 13G/A 5.8% 2y
RAFFLES ASSOCIATES LP PROV Provident Financial Holdings Inc 13G/A 5.6% 2y
CITADEL ADVISORS LLC DBTX Decibel Therapeutics, Inc. Common Stock 13G/A 0% 2y
FIR TREE CAPITAL MANAGEMENT LP TETWF Technology & Telecommunication Acquisition Corp 13G 9.49% 2y
ALLIANCEBERNSTEIN L.P. MGY Magnolia Oil & Gas Corp 13G/A 3.4% 2y
BOOTHBAY FUND MANAGEMENT, LLC ECDA ECD Automotive Design, Inc. 13G/A 3.1% 2y
Atreides Management, LP ACVA ACV Auctions Inc. 13G/A 8.09% 2y
AWM Investment Company, Inc. TBCH Turtle Beach Corp 13G/A 6.3% 2y
OceanLink Partners Fund, LP QFIN Qfin Holdings, Inc. 13G 5.19% 2y
RTW INVESTMENTS, LP RLMD Relmada Therapeutics, Inc. 13G/A 0% 2y
Fundsmith LLP BF-B Brown Forman Corp 13G/A 5.1% 2y
PERCEPTIVE ADVISORS LLC LRMR Larimar Therapeutics, Inc. 13G/A 0% 2y
FIR TREE CAPITAL MANAGEMENT LP MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares 13G 8.12% 2y
MACKENZIE FINANCIAL CORP TIXT TELUS International (Cda) Inc. Subordinate Voting Shares 13G/A 8.76% 2y
G1 Execution Services, LLC BURU Nuburu, Inc. 13G/A 0.3% 2y